MGY,Magnolia Oil & Gas Corporation | Energy

Energy

MGY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Magnolia Oil & Gas CorporationMGY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Magnolia Oil & Gas Corporation engages in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids reserves in the United States.

Its properties are located primarily in Karnes County and the Giddings area in South Texas principally comprising the Eagle Ford Shale and the Austin Chalk formation.

The company was incorporated in 2017 and is headquartered in Houston, Texas.

Latest News >

FOCUS-Wall Street hires more senior bankers as growing confidence spurs deal rebound

Aug 25, 2025

* Hiring surge follows tariff-induced pause * Senior hires include Citigroup ( C/PN ) and UBS executives * Junior staff recruitment rose 200% in August, search firm says By Tatiana Bautzer, Saeed Azhar and Isla Binnie NEW YORK, Aug 25 (Reuters) - Wall Street banks have hired dozens of senior executives in recent months, as improved economic sentiment has spurred...

BRIEF-Beigene And Unit Sign Royalty Purchase Agreement With Royalty Pharma PLC's Unit

Aug 25, 2025

Aug 25 (Reuters) - Beigene Ltd: * SAY CO, UNIT SIGN ROYALTY PURCHASE AGREEMENT WITH ROYALTY PHARMA INVESTMENTS 2023 ICAV, UNIT OF ROYALTY PHARMA PLC * SAYS AGREED TO SELL RIGHTS TO ROYALTIES ON IMDELLTRA SALES OUTSIDE CHINA TO ROYALTY PHARMA INVESTMENTS 2023 ICAV FOR $885 MILLION UPFRONT Source text Further company coverage: (Reporting by Beijing Newsroom) ...

Wall Street hires more senior bankers as growing confidence spurs deal rebound

Aug 25, 2025

NEW YORK (Reuters) -Wall Street banks have hired dozens of senior executives in recent months, as improved economic sentiment has spurred mergers and IPOs after a lull earlier in the year due to concerns over the effect of U.S. tariffs. The surge in job-hopping, which typically occurs in the spring, illustrates how rising confidence has prompted banks to staff up...

Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million

Aug 25, 2025

(Reuters) -Royalty Pharma said on Monday it has signed a deal with BeOne Medicines to acquire a royalty interest in Amgen's drug for small cell lung cancer for up to $950 million. The deal gives Royalty Pharma access to roughly 7% of global net sales of the therapy, which won U.S. approval last year for patients with extensive-stage small cell...